Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Is Liberty Llyva Stock Trading Above Fair Value Price At 97.85 Down 0.15 20260410 Is Widepoint Corporation Wyy Stock Overvalued Now Price At 4.80 Down 2.24 20260406 Is Hudson Hpp Stock Risky Now Price At 5.98 Up 5.84 20260406 Will Educational Educ Stock Outperform S P 500 Price At 1.36 Up 5.08 20260406 TG Therapeutics Inc TGTX posts 873 percent year over year revenue growth despite large Q4 2025 earnings miss RVTY Revvity Inc posts Q4 2025 EPS beat but dips slightly as investors react to muted year over year revenue growth Endava DAVA Stock Is It a Solid Investment Choice Endava plc ADS posts 22 positive EPS surprise Morgan Stanley and Argus Research Reduce ADP Price Targets After Earnings Review Sell in May Pattern May Influence Crypto Markets as Seasonal Headwinds Approach Dropbox CoFounder Drew Houston to Transition from CEO to Executive Chairman After 19Year Tenure Chinas Seven Titans Tech Stocks Under Pressure as Deflation Concerns Outweigh AI Optimism Fed Dissenters Disagree with Rate Cut Signal in PostMeeting Statement NTPC Q4 Profit Surges 34 YoY to 10615 Crore Board Declares 35 Per Share Final Dividend SLDE Q1 2026 Earnings Strong Earnings Beat Highlights Improving Underwriting Performance APYX Q1 2026 Earnings EPS Beat Masks Revenue Uncertainty Shares Slip Nexa Resources Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher ALAB Q1 2026 Earnings EPS Beat Drives Positive Stock Movement ENTX Q1 2026 Earnings Significant EPS Beat Highlights Progress for Entera Bio BMO Q1 2026 Earnings Strong EPS Beat Drives Optimism Amid Steady Performance Charlton Aria Acquisition Corporation Rights CHARR Holds Steady at 011 SPAC Rights Remain RangeBound Vinci Compass Investments VINP Slips 29 Amid Selling Pressure LuxExperience LUXE Hovers Near Support After Marginal Decline Cognizant Technology Solutions CTSH Retreats 178 as Key Support Levels Come into Focus BioXcel Therapeutics BTAI Slips 088 as Stock Tests Support Near 107